APOE and Alzheimer disease: Furthermore, these results are aligned with a meta-analysis assessing the link between APOE ε4 and sex differences, reporting that age differentially affected the risk of developing MCI and AD, with an increased risk of developing AD in women between 65 and 75 y of age (27).